opusgtx.com - IRD Net Assets per Single Share

Public company logo of Opus Bio (IRD)

Opus Genetics Inc (IRD) is developing an innovative platform for the correction of rare visual mutations, as confirmed by the BVPS metric; the -0.16 mark serves as the key value on this chart. The company is implementing robotic bioreactors for the precise control of therapy vectors. The orphan biotech model allows for the minimization of micro-dose production costs while ensuring high net margins through monopoly pricing power.

Accounting Value of a Share: Opus Bio (IRD) for 10/25/2024 - 10/26/2026

Opus Genetics, Inc. - analytical breakdowns and key metrics (IRD)

- price and consensus price forecast:
Stock Price Opus Bio|IRD - Broker Consensus Forecast
- market capitalization data:
Market Value Opus Genetics Inc|IRD - Full Business Value
- book capitalization data:
Book Value per Share Opus Genetics|IRD - Accounting Value of Company|Market Capitalization to Book Value Ratio opusgtx.com|IRD - Company Total Assets
- debt and liquidity data:
Debt to Equity Opus Genetics Inc|IRD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Opus Bio|IRD - Company Total Debt|Debts to Book Capitalization Opus Genetics Inc
Analysis of all company metrics:opusgtx.com (IRD)
Signature product of Opus Bio

Investors utilize this metric as an objective criterion for capital preservation, assessing the residual value of assets minus liabilities per share. Analyzing the book value per share indicator reveals that the capital stability of Opus Genetics Inc. (IRD) is supported by the high loyalty of its unique staff of geneticists and GMP manufacturing experts, which minimizes the risk of operational losses.

Competitor analysis

Alcon Vision (ALC) - Book Value per Share|BLCO: Equity per Share|Net Assets per Single Share Glaukos Corporation (GKOS)|apellis.com (APLS) - Share Book Value|BLTE - Book Value per Share|Accounting Value of a Share Ocular Therapeutix Inc|Book Value per Share HROW|Book Value per Share VRDN (Viridian Corp)|Net Assets per Single Share LENZ Therapeutics, Inc.|Oculis Pharma - Accounting Value of a Share|EYPT: Net Assets per Single Share|KOD - Accounting Value per Share|ALDX: Book Value per Share|Book Value per Share KALA BIO|OKYO - Accounting Value per Share|Accounting Value of a Share Adverum|Outlook Therapeutics, Inc. - Book Value per Share|Net Asset Value per Share Clearside Biomedical Inc CLSD|NBY: Accounting Value per Share|Net Asset Value per Share Kiora Pharmaceuticals Inc. KPRX|ALIM (Alimera) - Book Value per Share|EYEN: Net Asset Value per Share|Guardion Health Sciences - Net Assets per Single Share|OCUP (Ocuphire Pharma Inc) - Net Assets per Share|Net Assets per Single Share OPT (Opthea Ltd.)